RANI THERAPEUTICS HOLDINGS INC. - CLASS A COMMON

Rani Therapeutics to Present Abstract on RT-102 at the 2023 Annual Meeting of the American Society for Bone and Mineral Research

12 Oct 2023 15:05:00 By Nasdaq GlobeNewswire

Rani Therapeutics Initiates Phase 1 Study of RT-111 (RaniPill® Containing Ustekinumab Biosimilar, CT-P43)

18 Sep 2023 07:00:00 By Nasdaq GlobeNewswire

Rani Therapeutics Announces Successful Drug Delivery of High-Capacity Pill in Preclinical Studies

07 Sep 2023 15:05:00 By Nasdaq GlobeNewswire

Rani Therapeutics to Participate in September Investor Conferences

06 Sep 2023 07:00:00 By Nasdaq GlobeNewswire

Rani Therapeutics Reports Second Quarter 2023 Financial Results; Provides Corporate Update

11 Aug 2023 15:05:00 By Nasdaq GlobeNewswire

Rani Therapeutics to Participate in August Investor Conferences

04 Aug 2023 15:05:00 By Nasdaq GlobeNewswire

Rani Therapeutics’ Presentation On Oral Delivery of PTH for Osteoporosis Named Presidential Poster Competition Winner at ENDO 2023 Annual Conference

21 Jun 2023 07:00:01 By Nasdaq GlobeNewswire

Rani Therapeutics Announces Acceptance of Late-Breaking Abstract of Oral Delivery of GLP-1 Agonist at the American Diabetes Association Annual Conference

08 Jun 2023 07:00:00 By Nasdaq GlobeNewswire

Rani Therapeutics and Celltrion Expand Partnership to Include Adalimumab Biosimilar for RT-105

05 Jun 2023 07:00:02 By Nasdaq GlobeNewswire

Rani Therapeutics to Present at the Jefferies Healthcare Conference

01 Jun 2023 07:00:01 By Nasdaq GlobeNewswire

Rani Therapeutics Announces Acceptance of Three Abstracts for Presentation at ENDO 2023 Annual Conference

31 May 2023 07:00:01 By Nasdaq GlobeNewswire

Rani Therapeutics Appoints Kate McKinley as Chief Business Officer

24 May 2023 07:00:02 By Nasdaq GlobeNewswire

Rani Therapeutics Reports First Quarter 2023 Financial Results; Provides Corporate Update

10 May 2023 15:05:01 By Nasdaq GlobeNewswire

Rani Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ

25 Apr 2023 07:00:01 By Nasdaq GlobeNewswire

Rani Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference

11 Apr 2023 07:00:01 By Nasdaq GlobeNewswire

Rani Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Corporate Update

22 Mar 2023 15:05:00 By Nasdaq GlobeNewswire

Rani Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Business Updates

16 Mar 2023 15:05:00 By Nasdaq GlobeNewswire

Celltrion and Rani Therapeutics Partner on Development of Oral Monoclonal Antibody Treatment

09 Jan 2023 07:30:00 By Nasdaq GlobeNewswire

Rani Therapeutics Receives Feedback from Pre-IND Meeting with FDA; Provides Pipeline Update

05 Jan 2023 15:05:00 By Nasdaq GlobeNewswire

Rani Therapeutics Announces Repeat-Dose Topline Results from RT-102 Phase 1 Study

06 Dec 2022 15:05:00 By Nasdaq GlobeNewswire